PATENT CLAIM ANALYSIS

Application Number: 15861492
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "178000"]

Abstract:
Provided oral testosterone undecanoate compositions can be administered to hypogonadal males with a meal without the fat content of the meal substantially effecting bioavailability.

Claim (Index 20):
The pharmaceutical composition of  claim 19 , wherein said pharmaceutical composition is pharmaceutically equivalent to an oral pharmaceutical composition having about 75 mg or about 112.5 mg of testosterone undecanoate at 15 wt % loading, 63 wt % Maisine 35-1, 16 wt % Cremophor RH 40, and 6 wt % PEG 8000.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 86.0
- Lexical Diversity: 1.08696
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14952796', '15485154', '14691229', '15818697', '15594508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8145945140986588
- 35 USC 102 Novelty (BERT): 0.5393104892204703
- Combined Prediction Score: 0.78706611161084
- Mean Citation Score: 373.482492
- Max Citation Score: 396.47708
- Similarity Product: 231.7623168636728

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test